ISSN: 2052-8426 (Online Version)
Preparing your manuscript
Molecular and Cellular Therapies publishes the following article types:
1. Research Article Preparing: Please refer the publication style of Clinical and
Translational Medicine (clintransmed.springeropen.com).
Title page: The title page should include the title, the full names, institutional addresses
and email addresses for all authors, and the full information of the corresponding author
Abstract: The abstract should be less than360 words, with minimized use of
abbreviations and without cite references. The abstract must include Background with
aims, Results with main findings, and Conclusions.
Keywords: Please provide 5-6 keywords representing the main content of the article.
Background: The Background section should explain the background to the study, its
aims, a summary of the existing literature and aims of designed study.
Methods: The methods should include design and setting of the study, participants,
materials, all processes, interventions and comparisons, as well as statistical analysis
Results: The Results should include the main findings of the study, statistical analysis,
and tables and figures.
Discussion: The Discussion should include the implications of the findings, highlight
outstanding points and limitations of the study, explain study protocols and methodology,
and future potentials and indications.
Conclusions: The Conclusion should include a clear summary of main findings,
emphasize the importance and relevance of the study to the application, and indicate
Abbreviations: All abbreviations used in the text they should be defined in the text at first
appearance, and a list of abbreviations should be provided.
Ethics: Ethics approval and consent should be clearly addressed in the text. Manuscripts
involving human participants, human data or human tissue must include a statement on
ethics approval and consent (even where the need for approval was waived) and the
name of the ethics committee that approved the study and the committee’s reference
number. Studies involving animals must include a statement on ethics approval.
Competing interests: All financial and non-financial competing interests must be
declared in this section.
Funding: All sources of funding for the research reported should be declared.
Authors' contributions: The section should clarify the individual contributions of each
author to the study.
Acknowledgements: The section should describe the appreciation for one who helps the
article, with the permission from all those mentioned in the Acknowledgements section.
Authors' information: The section requests each author provide the name, academic
title, affiliation, brief description of research projects, and outstanding contributions made.
Authors’ information will be listed in a separate Experts section of home page.
Image: All images must be submitted with a resolution of at least 500 dpi. Scanned
figures are not acceptable. Please note that our production department can request
changes to the artwork when the manuscript is first evaluated (immediately after
submission) AND with the first copyedit.
All review/mini-review articles are invited by the Editorial Board of Molecular and Cellular
Therapies and should meet the following criteria within the scope of Molecular and
- Focus on the latest and front-line science and topics
- Discuss certain areas and topics with multi-opinions and comments
- Analyze the progress in specified areas
- Present systemic figures and full picture of specified molecules or cells
Review article is expected to be less than 6000 words, 8 figures, and 100 references.
Editorials/Perspectives/Commentaries bring the most attention on important issues, topics, and
areas, promote the discussion either by the phrasing of new hypotheses, alternative interpretations
of existing work, or by the presentation of new proposals for tackling existing
problems. Commentaries should be short and narrowly focused on contemporary interest.
Editorials/Perspectives/Commentaries are mostly invited and should be no longer than 1500 words, 1
figure, and 10 references.
4. Case Report/Short Communication
Case Report/Short Communication will publish original and interesting case reports or
short research data that contribute significantly to medical knowledge. Manuscripts should present
unusual side effects or adverse interactions, unusual presentations of a disease, or new light
on the possible pathogenesis of a disease. Case Report/Short Communication should
be no longer than 2000 words, 3 figures, and 30 references.